Wei Yue, Ph.D.

Associate Professor
Pharmaceutical Sciences
Phone (405) 271-6593 x47828
Fax (405) 271-7505
Office CPB 328
Email wei-yue@ouhsc.edu
Faculty Website https://sites.google.com/view/yuelab
Summary
My research program focuses on studying novel mechanisms involved in regulation of OATP1B1 and OATP1B3 transport function. The long-term goal of my laboratory is to establish a mechanistic model to predict OATP-mediated drug-drug interactions, toxicities and inter-individual variability in drug response. Multi-disciplinary approaches are utilized including: 1) Sandwich-cultured primary human hepatocytes model; 2) Physiologically based pharmacokinetic (PBPK) modeling approach to assess clinically relevant DDIs; 3) Pharmacogenomics studies of drug transport proteins; 4) Post-translational regulation of OATP transporters; 5) Confocal microscopy to study trafficking of the transport proteins.
Academic Awards
Member, Educators for Excellence
OUHSC
April 2022Publications & Presentations
- 11. Kayesh R, Farasyn T, Crowe A, Liu Q, Pahwa S, Alam K, Neuhoff S, Hatley O, Ding K, Yue W. Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models. Journal of pharmaceutical sciences. 2021; 110 : 314-324
12. Crowe A, Yue W. Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio-Protocol. 2019
13. Liu Q, Keyesh R, Farasyn T, Li Y, Vu N, Kupiec T, Yue W. A sensitive quantification method of unbound vemurafenib in human plasma using equilibrium dialysis followed by ultra-performance liquid chromatography coupled to a tandem mass spectrometry. PharmSci 360-AAPS Annual Meeting. 2019
14. Kayesh R, Farasyn T, Crowe A, Liu Q, Pahwa S, Alam K, Ding K, Neuhoff S, Hatley O, Yue W. Assessing OATP1B1- and OATP1B3-mediated drug-drug interaction potential of vemurafenib using static and physiologically based pharmacokinetic models. PharmSci 360-AAPS Annual Meeting. 2019
15. Wang L, Yue W, Hu M. Cellular uptake kinetic studies of Wogonoside, Luteolin 3’-glucuronide and apigenin 7-glucuronide in OATP1B1, 1B3 and 2B1 overexpressed HEK-293 cell lines. PharmSci 360-AAPS Annual Meeting. 2019
Grants
- 1. Equipment supplement award-Regulation of OATP1B1 and OATP1B3 by lysine acetylation and lysine deacetylase inhibitors . NIH. Start Date: 2024. End Date: 2026.
2. Regulation of OATP1B1 and OATP1B3 by lysine acetylation and lysine deacetylase inhibitors . NIH. Start Date: 2022. End Date: 2026.
3. Regulation of OATP1B1 and OATP1B3 by lysine acetylation and lysine deacetylase inhibitors . Misc Non-Federal. Start Date: 2022. End Date: 2022.
4. Lysine Acetylation: A novel mechanism governing organic anion transporting polypeptides OATP1B1- and OATP1B3-mediated transport. Misc Non-Federal. Start Date: 2021. End Date: 2022.
5. Elucidating novel mechanism underlying OATP1B1/1B3-mediated drug-drug interactions . Non-federal. Start Date: 2019. End Date: 2020.
Awards and Honors
- 1. OUHSC. Regents’ Award for Superior Teaching. Date: 2024.
2. ASPET. ASPET IDEA Faculty Scholars. Date: 2024.
3. WiSDMH at OUHSC. Recognition of OUHSC Women in Science Dentistry Medicine and Health. Date: 2022.
4. OUHSC. Member of Educators for Excellence of OUHSC. Date: 2022.
5. OUHSC. Provost’s Teaching Award-Early Career Faculty . Date: 2021.
Education
- 1. Degree: Postdoctoral training. Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Date: 2008.
2. Degree: Postdoctoral Training. Lineberger Comprehensive Cancer Center, Univeristy of North Carolina at Chapel Hill. Date: 2007.
3. Degree: Ph D. Peking Union Medical College and Shandong University, China. Date: 2001.
4. Degree: MS. Shandong University, China. Date: 1998.
5. Degree: BS. Shandong Agricultural University, China. Date: 1995.
Administrative Assignments
no results